刘海;贾守薇;刘业娜;谭思瑶;林子超;
LIU Hai;JIA Shouwei;LIU Yena;TAN Siyao;LIN Zichao;Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation for Cancer Medicine;

• 1:中山大学肿瘤防治中心药学部华南肿瘤学国家重点实验室肿瘤医学协同创新中心

摘要(Abstract)：

目的通过了解某肿瘤专科医院静脉配置中心退药情况,促进临床科室正确开医嘱与合理用药,加强药品质量管理提供参考。方法收集该院2018年7月～2019年6月退药申请5 713帖,按退药原因,按退药科室,退药品种3方面统计退药帖数、退药金额及其所占的比率进行回顾性分析。结果退药帖数最多及退药金额最大的前3项原因依次是修改医嘱、病情变化、未写原因。而申请退药帖数最多的前3个科室依次为内科、放疗科、鼻咽科,退药金额最大前3个科室依次为内科、放疗科、综合科。退药帖数及金额最多的药品为抗代谢类抗肿瘤药、铂类抗肿瘤药、植物类抗肿瘤药。结论静脉配置中心应加强退药管理,加强医患沟通,加强合理用药,减少退药。
OBJECTIVE To understandthe specific circumstances of drug refunds in PIVAS of specialist hospitaland to promote the clinical departments to use drugreasonably and provide reference for strengthening the quality control of drugs. METHODS 5 713 applications for drug refund by the PIVAS of specialist hospital in July 2018 to June 2019 were collected. After sorted through the reasons for drug refund,the variety of refund and the departments of drug refund,the types of drugs refunded,the sum of refunds and the ratio of refunds were analyzed retrospectively. RESULTS The reason of the largest of quantity and proportion for drug refund and the largest amount were from doctor' s advicerevise,patients' condition change,the writings without reason. The largest amounts with drug refunds departmentwere internal medicinet,radiotherapy and nasopharyngolog. The largest quantity with drug refund were internal medicine,radiotherapy,and integrated branch. Drugs with the largest number and amount of drug refunds were anti-metabolism antitumor drugs,platinum anti-tumor drugs and plant anti-tumor drugs. CONCLUSION The PIVAS should strengthen the management of drug refund,strengthen the communication between doctors and patients,strengthen drug userationally,and reduce drug refund.

关键词(KeyWords)： 静脉配置中心;药品管理;退药帖数;统计分析
PIVAS;quantity of drug refund;drugs management;statistical analysis

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 刘海;贾守薇;刘业娜;谭思瑶;林子超;
LIU Hai;JIA Shouwei;LIU Yena;TAN Siyao;LIN Zichao;Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation for Cancer Medicine;

Email:

DOI:

参考文献(References)：

• [1]鲁萍，李惠英，茹毅，等．降低我院PIVAS静脉用药调配过程中的差错数[J]．世界最新医学信息文摘，2018,18(53):109-110．
• [2]丁瑜吉，郁继忠，何迪，等．PIVAS退药管理及持续质量改进[J]．上海医药，2019,40(5):67-70．
• [3]观荣贵，丘九望，王琳环，等．某院日间化疗中心PIVAS的实践与探讨[J]．今日药学，2018,28(11):771-774．
• [4]张方予，周捷，庄浩裕，等．2017年某院中心药房退药情况分析[J]．今日药学，2018,28(7):490-492,496．
• [5]朱文靖，邱季．我院静脉用药调配中心细节化控制对提高调配安全性的作用[J]．实用药物与临床，2017,20(11):1347-1350．
• [6]彭秋燕，王倩，荆颖，等．我院静脉药物配置中心退药现状及原因分析[J]．天津药学，2018,30(5):45-47．
• [7]李江华，张兆桢，杨煊，等．1607例住院患者退药分析[J]．中国医院用药评价与分析，2008,8(4):312-313．
• [8]向左娟，王尔兵，龙明辉，等．我院静脉药物配置中心退药情况的分析与讨论[J]．肿瘤药学，2015,5(6):476-480．
• [9]张广德，梁丹，辛莉．我院门诊药房退药分析与思考[J]．世界最新医学信息文摘，2017,17(68):192-193．
• [10]吕伟标，刘建辉，屈红伶，等．广东顺德大样本人群鼻咽癌筛查状况分析[J]．广东医学，2018,39(2):86-88．
• [11]石坚如，胡苑婷，梁莉君．我院静脉配置中心退药原因分析[J]．海峡药学，2018,30(3):220-221．
• [12]梁斯敏，陈郁．2017年我院中心药房退药分析及改进措施[J]．临床合理用药杂志，2018,11(7):4-5．
• [13]夏英华，郁红星，毛燕君．某医院静脉药物配置中心退药现状调查分析[J]．中国护理管理，2013,13(7):49-51．
• [14]李文，程萍．2016年-2018年我院门诊药房退药数据分析及干预措施[J]．临床医药文献电子杂志，2019,6(59):12-13．
• [15]李清，冯基，苏畅．2018年某院住院药房退药分析及改进措施[J]．实用医技杂志，2019,26(9):1198-1199.